Literature DB >> 8890676

Changes in depressive symptoms as AIDS develops. The Multicenter AIDS Cohort Study.

C G Lyketsos1, D R Hoover, M Guccione, M A Dew, J E Wesch, E G Bing, G J Treisman.   

Abstract

OBJECTIVE: The authors sought to determine whether rates of depressive symptoms change from early- to late-stage HIV-1 infection and to determine the predictors of depressive symptoms as AIDS develops.
METHOD: The data for this study were from 911 HIV-seropositive men-community volunteers from four U.S. cities-who entered the 10-year Multicenter AIDS Cohort Study without a diagnosis of AIDS and subsequently developed AIDS. The subjects underwent semiannual follow-ups during the study period. The outcome measures-overall depressive symptoms, nonsomatic depressive symptoms, syndromal depression, and severe depression-were assessed over the 5 years before and the 2 years after AIDS diagnosis from responses on the Center for Epidemiologic Studies Depression Scale (CES-D Scale).
RESULTS: Depressive symptoms were stable over time from month 60 to month 18 before AIDS developed. However, beginning 12-18 months before AIDS diagnosis, there was a significant rise in all measures of depression, which reached a plateau within 6 months before AIDS developed. At this plateau, there was a 45% increase in mean CES-D Scale scores above baseline. An elevated CES-D Scale score in the earlier stages of infection, a self-report of AIDS-related symptoms (such as rash and lymphadenopathy), concurrent unemployment, cigarette smoking, and limited social supports were consistent predictors of higher rates of depression as AIDS developed.
CONCLUSIONS: There is a dramatic, sustained rise in depressive symptoms as AIDS develops, beginning as early as 18 months before clinical AIDS is diagnosed. Prior depression, HIV-disease-related factors, and psychological stressors contribute to this rise. This robust phenomenon invites further characterization.

Entities:  

Mesh:

Year:  1996        PMID: 8890676     DOI: 10.1176/ajp.153.11.1430

Source DB:  PubMed          Journal:  Am J Psychiatry        ISSN: 0002-953X            Impact factor:   18.112


  48 in total

Review 1.  Neuropsychiatric complications of aging with HIV.

Authors:  Crystal C Watkins; Glenn J Treisman
Journal:  J Neurovirol       Date:  2012-05-30       Impact factor: 2.643

Review 2.  Drug treatment of depression in HIV-positive patients : safety considerations.

Authors:  Andrew A Pieper; Glenn J Treisman
Journal:  Drug Saf       Date:  2005       Impact factor: 5.606

3.  Clinical, laboratory, and neuroimaging characteristics of fatigue in HIV-infected individuals.

Authors:  Giovanni Schifitto; Lijuan Deng; Tzu-Min Yeh; Scott R Evans; Thomas Ernst; Jianhui Zhong; David Clifford
Journal:  J Neurovirol       Date:  2010-12-23       Impact factor: 2.643

Review 4.  Safety considerations in drug treatment of depression in HIV-positive patients: an updated review.

Authors:  Crystal C Watkins; Andrew A Pieper; Glenn J Treisman
Journal:  Drug Saf       Date:  2011-08-01       Impact factor: 5.606

Review 5.  Reliability and validity of depression assessment among persons with HIV in sub-Saharan Africa: systematic review and meta-analysis.

Authors:  Alexander C Tsai
Journal:  J Acquir Immune Defic Syndr       Date:  2014-08-15       Impact factor: 3.731

6.  Stigma, social support, and depression among people living with HIV in Thailand.

Authors:  Li Li; Sung-Jae Lee; Panithee Thammawijaya; Chuleeporn Jiraphongsa; Mary Jane Rotheram-Borus
Journal:  AIDS Care       Date:  2009-08

7.  Endocrine modulation of the neurotoxicity of gp120: implications for AIDS-related dementia complex.

Authors:  S Brooke; R Chan; S Howard; R Sapolsky
Journal:  Proc Natl Acad Sci U S A       Date:  1997-08-19       Impact factor: 11.205

8.  Cigarette smoking among HIV+ men and women: examining health, substance use, and psychosocial correlates across the smoking spectrum.

Authors:  Monica S Webb; Peter A Vanable; Michael P Carey; Donald C Blair
Journal:  J Behav Med       Date:  2007-06-15

9.  Depression symptoms and cognitive function among individuals with advanced HIV infection initiating HAART in Uganda.

Authors:  Noeline Nakasujja; Richard L Skolasky; Seggane Musisi; Peter Allebeck; Kevin Robertson; Allan Ronald; Elly Katabira; David B Clifford; Ned Sacktor
Journal:  BMC Psychiatry       Date:  2010-06-10       Impact factor: 3.630

10.  Psychiatric context of acute/early HIV infection. The NIMH Multisite Acute HIV Infection Study: IV.

Authors:  J Hampton Atkinson; Jenny A Higgins; Ofilio Vigil; Robert Dubrow; Robert H Remien; Wayne T Steward; Corinna Young Casey; Kathleen J Sikkema; Jackie Correale; Chris Ake; J Allen McCutchan; Peter R Kerndt; Stephen F Morin; Igor Grant
Journal:  AIDS Behav       Date:  2009-06-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.